Newer biologic and small-molecule therapies for inflammatory bowel disease
DC Baumgart, C Le Berre - New England Journal of Medicine, 2021 - Mass Medical Soc
New England Journal of Medicine, 2021•Mass Medical Soc
Newer Biologic and Small-Molecule Therapies for IBD There is still no cure for inflammatory
bowel disease. This review covers newer treatments that reflect our understanding of the
complex pathogenesis of IBD, with a focus on clinical and endoscopic remission and more
precise molecular targeting of inflammatory cascades.
bowel disease. This review covers newer treatments that reflect our understanding of the
complex pathogenesis of IBD, with a focus on clinical and endoscopic remission and more
precise molecular targeting of inflammatory cascades.
Newer Biologic and Small-Molecule Therapies for IBD
There is still no cure for inflammatory bowel disease. This review covers newer treatments that reflect our understanding of the complex pathogenesis of IBD, with a focus on clinical and endoscopic remission and more precise molecular targeting of inflammatory cascades.
The New England Journal Of Medicine